Share on StockTwits

Analysts at Cowen and Company dropped their target price on shares of Hansen Medical (NASDAQ:HNSN) from $3.00 to $2.50 in a research report issued to clients and investors on Tuesday. The firm currently has an “outperform” rating on the stock. Cowen and Company’s price target would indicate a potential upside of 89.39% from the stock’s previous close.

Hansen Medical (NASDAQ:HNSN) traded up 10.61% during mid-day trading on Tuesday, hitting $1.46. 995,466 shares of the company’s stock traded hands. Hansen Medical has a 52 week low of $1.10 and a 52 week high of $2.89. The stock’s 50-day moving average is $2.07 and its 200-day moving average is $2.05. The company’s market cap is $150.9 million.

Hansen Medical (NASDAQ:HNSN) last released its earnings data on Wednesday, May 7th. The company reported ($0.14) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.11) by $0.03. The company had revenue of $3.69 million for the quarter, compared to the consensus estimate of $4.94 million. During the same quarter last year, the company posted ($0.26) earnings per share. Hansen Medical’s revenue was up 25.1% compared to the same quarter last year. On average, analysts predict that Hansen Medical will post $-0.45 earnings per share for the current fiscal year.

Hansen Medical, Inc develops, manufactures and markets a generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.